Skip to main content
. 2014 Oct 15;16(5):458. doi: 10.1186/s13075-014-0458-4

Figure 1.

Figure 1

Study design. This was a double-blind, crossover randomized controlled trial. Patients were randomized to receive either methotrexate (MTX) or placebo (PBO) during an initial treatment period of three months, followed by a ‘wash-out’ phase of two months and a crossover second treatment period of three months. The T + X (↓) represent monthly assessments since randomization; the status (↑) represent medical visits with a clinical examination.